Palivizumab Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Palivizumab Injection (injection) from Swedish Orphan Biovitrum AB with status To Be Discontinued. The shortage was first posted on 08/13/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Swedish Orphan Biovitrum AB
- Package NDC
- 66658-230-01
- Dosage Form
- Injection
- Presentation
- Synagis, Injection, 50 mg/.5 mL (NDC 66658-230-01)
- Initial Posting
- 08/13/2025
- Revised Date